Researchers One Step Closer To 'Obesity Drug'

By | Mon, 12/02/2013 - 17:18

A drug designed to inhibit inflammatory proteins may help obese and overweight people lose weight.


New Prescription Weight Loss Drug, Belviq, Hits The Market Today, But Is It Worth The Cost?

By | Wed, 06/12/2013 - 10:36

With a high cost and only marginal benefits, the new weight loss drug may not be helpful to a majority of people.


'Evergreen' Drugs Extend Pharma Patents, May Have Cost Swiss Consumers 30M Euros

By | Tue, 06/04/2013 - 17:04

A new study estimates 'evergreen' policies that extend the life of drug patents substantially increased health care costs in Geneva.

melanoma GSK glaxosmithkine

FDA Approves Two Next-Gen Melanoma Drugs From GlaxoSmithKline; More Hope For Advanced Cancer Patients

By | Wed, 05/29/2013 - 17:25

GSK's new melanoma drugs are targeted toward specific mutations present in the skin cancer.

Novo nordisk

Diabetes Drug To Be Sold As Weight Loss Medication

By | Sun, 05/26/2013 - 11:41

Liraglutide (Victoza), currently approved to treat type 2 diabetes, will be re-branded and sold as a weight-loss aid.


FDA Grants Priority Review To ABRAXANE For Advanced Pancreatic Cancer

By | Thu, 05/23/2013 - 11:09

Already approved for breast cancer treatment, ABRAXANE has shown promise in increasing survival of advanced pancreatic cancer patients.

Merck Sleeping Pill

Merck Experimental Sleeping Pill, Suvorexant, Effective Says FDA

By | Mon, 05/20/2013 - 10:47

A promising sleeping pill, with fewer side effects than current drugs on the market, is in the midst of the FDA approval process.

Asthma drug shows results in trials

Sanofi Announces Positive Late Stage Trial Results For Myelofibrosis Drug

By | Fri, 05/17/2013 - 16:23

The new drug will soon be submitted to the FDA for approval to treat the blood cell proliferative disorder myelofibrosis.

Hepatitis C treatment gets FDA priority review

Simeprevir Given Priority Review Status By FDA For Hepatitis C Treatment

By | Mon, 05/13/2013 - 10:21

With stunning results in Phase III clinical trials, the hepatitis C drug is now on a fast track for FDA approval.

Small Molecule Universe Map

Scientists Map All Possible Drug Compounds in ‘Small Molecule Universe’

By | Mon, 04/22/2013 - 20:18

A computer algorithm has mapped all the possible carbon-based structures in the ‘small molecule universe’ that might be created as drugs in pharmaceutical labs— even chemical compounds that don’t exist yet.

IV Bag

FDA Approves of Imported Generic Cancer Drug Due to Shortages In Supply

By | Tue, 02/05/2013 - 10:05

The FDA has taken drastic measures to increase availability of Doxil, a cancer drug that is in short supply.